Florian Dismer
Papers
3
Total Citations
61
H-Index
3
About
Florian Dismer is a bioprocess engineer and pharmaceutical scientist whose research sits at the intersection of biopharmaceutical development, protein engineering, and high-throughput process optimization. His work has made meaningful contributions to accelerating and refining the development of biologics, particularly in the areas of PEGylation chemistry, protein solubility assessment, and protein refolding. Dismer's most impactful contribution — garnering 44 citations — centers on the optimization of random PEGylation reactions through high-throughput screening. PEGylation, a technique used to enhance the efficacy and stability of biopharmaceutical proteins, has been central to drug development since the first FDA-approved PEGylated product in 1990. His systematic approach to understanding how process parameters influence PEGylation outcomes addressed a longstanding challenge in the field. Complementing this, his work on automated measurement of apparent protein solubility and miniaturized protein refolding screening platforms demonstrates a consistent focus on reducing material consumption and accelerating development timelines through intelligent automation. Taken together, Dismer's research equips the biopharmaceutical industry with faster, more resource-efficient tools for process development — contributions that hold particular value as demand for complex biologic therapeutics continues to grow.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3